The National Pharmaceutical Pricing Authority (NPPA) has issued an update to its earlier Gazette notifications, 3000(E) dated July 4, 2025, and 3977(E) dated August 29, 2025, concerning the ceiling price fixation of scheduled I.V. fluid formulations (non-glass with special features). The update introduces four new clauses: (h5), (h6), (h7), and (h8).
Under clause (h5), for M/s IV Tech Healthcare and M/s Life Infusion Pharmaceuticals Pvt. Ltd., only formulations listed at Serial Numbers 1, 2, 3, 4, 5, 7, and 8 of Table A are covered. Clause (h6) applies to M/s Safal Lifescience Pvt. Ltd. and M/s One Drip Healthcare Pvt. Ltd., limiting applicable formulations to Serial Numbers 2, 4, 5, and 7. Clause (h7) specifies that for M/s Virchow Biotech Pvt. Ltd., formulations under Serial Numbers 1, 2, 4, 5, 6, 7, and 8 are valid. Clause (h8) states that M/s Klokter Life Sciences Pvt. Ltd. and M/s Zee Laboratories Ltd. are covered only for formulations numbered 2, 4, and 7.
These additions strengthen compliance and bring greater clarity to price applicability.